Latest Leadership News

Future Generation announces CEO Caroline Gurney will step down in early 2026, leaving behind a legacy of strong investment returns and $100 million donated to Australian non-profits. An executive search is underway to find her successor.

Lightning Minerals has launched its inaugural drilling campaign at the Mt Turner gold and silver project in Queensland, backed by a fresh A$2 million capital raise. Meanwhile, exploration advances across its lithium assets in Brazil signal a multi-commodity growth strategy.

Future Metals NL appoints Keith Bowes as CEO and initiates a strategic review of its flagship Panton project, leveraging rising platinum group metal prices and exploration successes. The company also completes a A$4.2 million capital raise and plans to delist from AIM.

Kelsian Group reported steady FY25 financial results with a 9.5% revenue increase and reaffirmed FY26 EBITDA guidance, while progressing the strategic divestment of its tourism assets to sharpen focus on core transport services.

Universal Store Holdings has reported robust FY25 results with revenue climbing 15.5% to $333.3 million and a dividend increase, signaling confidence despite retail headwinds. Early FY26 trading shows continued momentum.

BluGlass Limited reports a robust project pipeline exceeding US$100 million, bolstered by initial orders from Collins Aerospace and Infleqtion Inc, alongside strategic board appointments and a $6 million R&D tax rebate.

Medallion Metals has executed a binding agreement to acquire the Forrestania Nickel Operation from IGO, expanded its Ravensthorpe gold-copper resource to nearly 1 million ounces gold equivalent, and secured a $50 million prepayment facility with Trafigura to advance project development.

Arovella Therapeutics reported solid progress in Q1 FY26, moving closer to initiating its first-in-human trial for ALA-101 while securing key patents and maintaining a strong cash position.

Locksley Resources appoints Kerrie Matthews as Managing Director and CEO to spearhead the commercialisation of U.S.-produced antimony, following a landmark domestic metal ingot milestone.

NeuroScientific Biopharmaceuticals has secured regulatory approval for initial patient treatments under its Special Access Program for StemSmart™ in Crohn’s disease, alongside key executive appointments and a manufacturing partnership to support upcoming clinical trials.

Dalaroo Metals has broadened its gold footprint in Côte d’Ivoire with four new project acquisitions while completing initial exploration in Greenland’s critical minerals sector. A $1 million capital raise supports these strategic moves as leadership changes unfold.

Vital Metals has raised A$6.8 million through a strategic placement and refreshed its board to accelerate development of its Nechalacho Rare Earths and Niobium Project in Canada, with further funding pending shareholder approval.